Code | 4388E | ||||||||||
MA number | EU/1/23/1751/001 | ||||||||||
Product Form: | sol inj 1x0,1 ml/4 mg (liek.inj.skl. + ihla) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Biosimilar Collaborations Ireland Limited, Ireland | ||||||||||
Therapeutic Class: | 64 - OPHTHALMOLOGICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravitreal use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(4) similar biological application |
MA issued: | 15.09.2023 |
Validity: | 15.09.2028 |
SmPC + PL: | European Medicines Agency's database |
Safety feature | Yes |
Data update: | 06.12.2023 |